Dexfenfluramine

Dexfenfluramine is a pharmacological agent that was once used as an appetite suppressant in the management of obesity. It is the dextrorotatory form of fenfluramine, part of the fen-phen anti-obesity medication. However, due to concerns over its safety, dexfenfluramine was withdrawn from the market.

Medical Uses[edit | edit source]

Dexfenfluramine was primarily prescribed for individuals who were significantly overweight and for whom diet and exercise had not been effective. It worked by reducing appetite, thereby decreasing food intake.

Mechanism of Action[edit | edit source]

The drug functioned by increasing the release of serotonin in the brain, which is a neurotransmitter known to regulate mood and appetite. By enhancing serotonin levels, dexfenfluramine reduced appetite and food consumption. However, its exact mechanism of action was more complex and involved multiple neurotransmitter systems.

Side Effects[edit | edit source]

While dexfenfluramine was effective in reducing appetite, it was associated with several serious side effects. These included pulmonary hypertension, a rare but potentially fatal disorder, and heart valve problems. The risk of these side effects led to its withdrawal from the market.

Withdrawal from Market[edit | edit source]

In 1997, the U.S. Food and Drug Administration (FDA) requested the withdrawal of dexfenfluramine after confirming the association between the drug and serious cardiac side effects. Similar actions were taken in other countries, leading to a global discontinuation of the drug.

Legal and Ethical Considerations[edit | edit source]

The withdrawal of dexfenfluramine raised significant legal and ethical issues, including the adequacy of drug testing and approval processes, the responsibility of pharmaceutical companies in ensuring drug safety, and the role of regulatory agencies in protecting public health.

Current Status[edit | edit source]

As of the last update, dexfenfluramine is no longer available on the market, and its use is not recommended due to the risks associated with its consumption. Research into safer and more effective treatments for obesity continues.

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.